Proton Pump Inhibitors: Depresecribing and Polypharmacy Reduction is the best discussion of the risks and benefits of those drugs that I have ever seen in any medical conference

– Alan Cassels, Journalist and drug policy researcher.

About the program

Webinar: Thursday, June 18 – 8:00pm EST

This 1-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada for up to 1.25 Mainpro+ credits.

Presenter: John Gannage, MD, CCFP, FMAPS

Medical Director, Markham Integrative Medicine

Proton pump inhibitors (PPIs) are among the most frequently prescribed medications, yet research suggests they may be overused and lead to serious adverse outcomes including increased risks of cardiovascular events, kidney disease, infections, and essential nutrient deficiencies.

In this interactive continuing medical education webinar, Dr. John Gannage will highlight the potential dangers of long-term PPI use and provide practical information on deprescribing these drugs. He will also discuss ways to support optimal digestion through non-pharmaceutical interventions.

At the conclusion of this activity, participants will be able to:

  • Recognize the risks associated with long-term PPI use, including drug-induced nutrient depletion.
  • Analyze the underlying causes of low stomach acid and understand the functional implications of blocking its production.
  • Identify the rationale for deprescribing proton-pump inhibitors, particularly in the context of polypharmacy reduction and the management of chronic disease.
  • Evaluate non-pharmaceutical interventions for managing reflux symptoms and supporting digestive function.

CME Planning Committee

Rose Bilotta, MD, MHSc, CCFP, FRCPC, DABPM, IFMCP
Selena Bloom, MD, MCFP, SEP
John Gannage, MD, CCFP, FMAPS

Free continuing medical education webinar intended for health care professionals and students currently enrolled in medical, nurse practitioner or pharmacy programs.